UK Company, Stablepharma Ltd, enters Phase 1 Clinical Trials with world-first Fridge-Free Tetanus & Diphtheria Vaccine

World’s first vaccines that don’t need refrigeration just entered trials

Vaccines have saved millions of lives. But keeping them cold has always been a challenge. In many parts of the world, transporting and storing vaccines means relying on a fragile and costly refrigeration system. Now, a British biotech company may have found a way around it. Human trials have begun for the world’s first unrefrigerated vaccines, a potential game-changer in global health. The innovation comes from Stablepharma, a UK-based company w…

World’s first trial of room-temperature vaccine gets underway

The NewsThe world’s first trial of a room-temperature vaccine began in the UK. Existing vaccines need to be kept in refrigerators — and, in some cases, ultra-low-temperature freezers, a huge obstacle to getting them to where they are needed, especially in low-income countries with limited electricity supplies.A British biotech company said its technology can ensure existing vaccines are stable at room temperature. The initial test is on a tetanu…

World-first clinical trial launched in the UK for a fridge-free vaccine

One of the biggest barriers to people getting vaccines in some parts of the world is the ‘cold chain’ required to keep vaccines cold.

UK Company, Stablepharma Ltd, enters Phase 1 Clinical Trials with world-first Fridge-Free Tetanus & Diphtheria Vaccine

LONDON, April 29, 2025 (GLOBE NEWSWIRE) -- Following MHRA approval, Stablepharma Ltd has commenced a Phase 1 clinical trial with its lead candidate, fridge-free tetanus and diphtheria vaccine, SPVX02. The Phase 1, first-in-human clinical trial led by Professor Saul Faust, is being conducted at the National Institute for Health and Care Research (NIHR) at Southampton Clinical Research Facility. Stablepharma's pioneering science has progressed int…

The world’s first clinical trial of a vaccine that can be stored at room temperature has begun in the UK, paving the way for wider and easier access to vaccination worldwide. The tetanus-diphtheria vaccine (SPVX02), developed by Stablepharma, is completely stable at room temperature. According to the company, up to 60 other vaccines could benefit from the advanced technology it uses. The first human trial of the vaccine will take place at the Na…

Stablepharma begins first-in-human trial of “world-first” fridge-free vaccine

The World Health Organization estimates that 50% of vaccines are wasted globally each year due to cold chain issues.The post Stablepharma begins first-in-human trial of “world-first” fridge-free vaccine appeared first on Clinical Trials Arena.